CasLoc logo
All Cases PTAB Litigations UPC Oppositions

OSI Pharmaceuticals, LLC v. Apotex Inc.

1:15-cv-00772

Overview

Case Number 1:15-cv-00772
Filing Date 2015-09-02
Status Terminated
Termination Date 2019-12-04
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Natco Pharma Ltd. Operating Company

Represented By

2 Attorneys Listed

Kelly E. Farnan

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7705

Richards, Layton & Finger, PA, One Rodney Square

Christine Dealy Haynes

Richards, Layton & Finger

Tel: +1 (302) 651-7508

Richards, Layton & Finger, 920 North King Street

Breckenridge Pharmaceutical Inc. Operating Company

Represented By

4 Attorneys Listed

Matthew L. Fedowitz

Email: matthew.fedowitz@bipc.com

Kelly E. Farnan

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7705

Richards, Layton & Finger, PA, One Rodney Square

Christine Dealy Haynes

Richards, Layton & Finger

Tel: +1 (302) 651-7508

Richards, Layton & Finger, 920 North King Street

Bruce J. Boggs

Email: jboggs@merchantgould.com

Apotex Corp. Operating Company

Represented By

6 Attorneys Listed

Ryan P. Blaney

Email: rblaney@cozen.com

Eric J. Choi

UNDELIVERABLE EMAIL 10/21/2020

Ryan P. Bottegal

Email: rbottegal@cozen.com

Kerry B. McTigue

Email: kmctigue@cozen.com

Thomas Joseph Francella , Jr.

Cozen & O'Connor

Tel: +1 (302) 295-2023
Fax: +1 (302) 250-4495

Cozen & O'Connor, Chase Manhattan Centre

Joseph J. Bellew

White & Williams

Tel: +1 (302) 467-4534
Fax: +1 (302) 467-4540

White & Williams, 600 North King Street, Suite 800

Apotex Inc. Operating Company

Represented By

8 Attorneys Listed

William Blake Coblentz

Email: wcoblentz@cozen.com

Ryan P. Bottegal

Email: rbottegal@cozen.com

Kerry B. McTigue

Email: kmctigue@cozen.com

Keri L. Schaubert

Email: kschaubert@cozen.com

Barry P. Golob

Email: bgolob@cozen.com

Aaron S. Lukas

Email: alukas@cozen.com

Thomas Joseph Francella , Jr.

Cozen & O'Connor

Tel: +1 (302) 295-2023
Fax: +1 (302) 250-4495

Cozen & O'Connor, Chase Manhattan Centre

Joseph J. Bellew

White & Williams

Tel: +1 (302) 467-4534
Fax: +1 (302) 467-4540

White & Williams, 600 North King Street, Suite 800

Plaintiff

Pfizer Inc. Operating Company

Represented By

3 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Genentech, Inc. Operating Company

Represented By

3 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

OSI Pharmaceuticals, LLC Operating Company

Represented By

8 Attorneys Listed

Tracey C. Allen

UNDELIVERABLE EMAIL 6/16/2021

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Kevin M. Yurkerwich

Email: kevin.yurkerwich@wilmerhale.com

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Amy K. Wigmore

Email: amy.wigmore@wilmerhale.com

Amanda L. Major

Email: amanda.major@wilmerhale.com

Allison B. Drory

Email: allison.drory@wilmerhale.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 2 proceedings
🏛️
USPTO PTAB Trials 1 proceeding
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (3 found):
PTAB: 1 U.S. Courts: 2
USPTO PTAB Trial 2016-06-28
IPR2016-01284

Apotex, Inc. et al. v. OSI Pharmaceuticals, LLC et al.

Asserted Patent
Status: Final Written Decision
U.S. District Court 2012-12-07
1:12-cv-01669

OSI Pharmaceuticals LLC v. Roxane Laboratories Inc.

Asserted Patent
Status: DED
U.S. District Court 2012-04-13
1:12-cv-00465

OSI Pharmaceuticals LLC v. Roxane Laboratories Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6900221
Stable polymorph on N-(3-ethynylphenyl)-6, 7-bis (2methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof
Filed: 2000-11-09
Issued: 2005-05-31
Expired (Term Ended)
Expires: 2020-11-09
US7087613
Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
Filed: 2004-11-18
Issued: 2006-08-08
Expired (Term Ended)
Expires: 2024-11-18

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

20

Dispositive

0

Granted

2

Denied

0

Pending / Review

8

Motions by Category

Procedural / Extension Motion 18 Claim Construction / Markman Filing 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
SO ORDERED- re 67 Joint STIPULATION TO EXTEND TIME for production of documents to December 22, 2016. Signed by Judge Sherry R. Fallon on 12/7/2016. (lih)
Entry #— • 2016-12-07
Procedural / Extension Motion Pending / Under Review
Joint STIPULATION TO EXTEND TIME for production of documents to December 22, 2016 - filed by Genentech, Inc., OSI Pharmaceuticals, LLC, Pfizer Inc.. (Fahnestock...
Entry #67 • 2016-12-05 Document →
Procedural / Extension Motion Granted
ORDER granting 65 Joint STIPULATION to Extend Time for Completion of Discovery, AMENDED SCHEDULING ORDER DEADLINES: ( Fact Discovery completed by 2/17/2017., Ex...
Entry #66 • 2016-11-01 Document →
Procedural / Extension Motion Granted
Joint STIPULATION to Extend Time for Completion of Discovery by Genentech, Inc., OSI Pharmaceuticals, LLC, Pfizer Inc.. (Fahnestock, Derek) Modified on 10/28/20...
Entry #65 • 2016-10-27 Document →
Procedural / Extension Motion Pending
SO ORDERED- re 63 Joint STIPULATION TO EXTEND TIME. Set Scheduling Order Deadlines ( Discovery due by 10/31/2016.) Signed by Judge Sherry R. Fallon on 9/13/2016...
Entry #— • 2016-09-13
Procedural / Extension Motion Pending / Under Review
Joint STIPULATION TO EXTEND TIME the time for completion of discovery of paper and electronic documents to October 31, 2016 - filed by Genentech, Inc., OSI Phar...
Entry #63 • 2016-09-12 Document →

Docket Entries

(171 total)
Pleading / Complaint

COMPLAINT filed against Apotex Corp., Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1780687.) - filed by OSI Pharmaceuticals, LLC, Genentech, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(nmb) (Entered: 09/03/2015)

Entry #1 • 2015-09-02
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmb) (Entered: 09/03/2015)

Entry #2 • 2015-09-02
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: July 21, 2015. Date of Expiration of Patent: May 9, 2021.Thirty Month Stay Deadline: 1/21/2018. (nmb) (Entered: 09/03/2015)

Entry #3 • 2015-09-02
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,900,221 B1;. (nmb) (Entered: 09/03/2015)

Entry #4 • 2015-09-02
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holdings, Inc., Other Affiliate Novartis AG, Other Affiliate Roche Holding Ltd. for Genentech, Inc.; Corporate Parent Astellas US LLC, Other Affiliate Astellas US Holding Inc., Other Affiliate Astellas Pharma Inc. for OSI Pharmaceuticals, LLC filed by Genentech, Inc., OSI Pharmaceuticals, LLC. (nmb) (Entered: 09/03/2015)

Entry #5 • 2015-09-02
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc